A Comprehensive Guide to CPT Codes for PET Scans

In the high-stakes, technologically advanced world of modern medicine, the Positron Emission Tomography (PET) scan stands as a pinnacle of diagnostic innovation. It allows physicians to peer into the inner workings of the human body, visualizing not just structure, but function and metabolism at a cellular level. It is a tool that can detect the silent metabolic activity of a nascent cancer, assess the blood flow to a struggling heart, or map the neural pathways of a complex brain disorder. For patients, a PET scan can be a source of profound hope or definitive answers, guiding life-altering treatment decisions.

Yet, for all its clinical sophistication, the value of this advanced technology is ultimately communicated through a deceptively simple language: a five-digit code. These Current Procedural Terminology (CPT) codes are the essential linchpin between the clinical service provided and the administrative and financial systems that sustain healthcare delivery. They are not arbitrary numbers; they are a precise, standardized vocabulary that tells the story of the procedure to insurance companies, regulators, and researchers.

A misunderstood or miscoded PET scan can lead to claim denials, significant revenue loss for healthcare providers, audit flags, and even compliance issues. Conversely, accurate coding ensures that the immense value of this diagnostic power is appropriately recognized and reimbursed, enabling imaging centers and hospitals to continue offering this vital service. This article is designed to be the definitive guide for radiologists, oncologists, neurologists, cardiologists, medical coders, healthcare administrators, and anyone who seeks to fully understand the intricate and crucial world of CPT codes for PET scans. We will move beyond a simple code list and delve into the science, the strategy, and the nuances that define accurate and successful PET imaging coding.

2. Understanding the Fundamentals: What is a PET Scan?

Before we can decode the codes, we must first understand the procedure they represent.

The Science Behind the Image: Radioligands and Metabolic Activity
A PET scan is a type of nuclear medicine imaging that reveals how tissues and organs are functioning at a molecular and metabolic level. The process begins with the administration of a radioactive drug known as a radiopharmaceutical or radiotracer. The most common tracer is Fluorodeoxyglucose F-18 (FDG), a molecule that is analogous to glucose, the primary energy source for cells.

Metabolically active cells, such as cancer cells, inflamed cells, or active brain neurons, are glucose “avid.” They consume glucose at a much higher rate than normal, surrounding tissues. When FDG is injected into the patient’s bloodstream, these hypermetabolic cells absorb it in large quantities. As the F-18 isotope decays, it emits positrons. These positrons almost immediately collide with electrons in the body in a process called annihilation, which produces two gamma photons traveling in opposite directions.

The PET scanner is a ring of detectors that captures these simultaneous photons. Using sophisticated computer algorithms, it pinpoints the origin of these annihilations and constructs a detailed, three-dimensional image that maps the metabolic activity throughout the body. Areas of high FDG uptake appear as “hot spots” or bright areas on the image, signaling potential disease.

A Brief History of PET Imaging
The foundations of PET were laid in the 1950s with the development of detector technology. The first PET scanners emerged in the 1970s for brain imaging, but it was the development and adoption of FDG in the late 1970s and 1980s that truly revolutionized the field. Its value in oncology became apparent in the 1990s, leading to widespread clinical use. The most significant advancement came in the early 2000s with the commercial integration of PET and CT scanners into a single PET/CT unit. This hybrid technology overlays the high-resolution anatomical images from a CT scan with the functional metabolic data from the PET scan, providing a comprehensive diagnostic picture that is far greater than the sum of its parts. More recently, PET/MRI systems have emerged, combining metabolic data with the superb soft-tissue contrast of MRI.

PET vs. CT vs. MRI: Understanding the Functional Advantage

• Computed Tomography (CT): Provides excellent detailed anatomical images of bones, organs, and tissues. It shows structure and is superb for identifying size, shape, and density of abnormalities.

• Magnetic Resonance Imaging (MRI): Also provides detailed anatomical images, particularly of soft tissues, without radiation. It excels in showing contrast between different soft tissues (e.g., brain matter, muscles, ligaments).

• Positron Emission Tomography (PET): Provides functional or metabolic information. It shows how an organ or tissue is working. A tumor may be invisible on a CT scan due to its size or location, but it can be detected by a PET scan due to its high metabolic activity long before it causes anatomical changes.

This functional advantage is what makes PET indispensable, particularly in oncology for diagnosing, staging, restaging, and monitoring response to therapy.

3. The CPT Code System: The Universal Language of Medical Procedures

What is the American Medical Association (AMA)?
The CPT code set is created, maintained, and copyrighted by the American Medical Association (AMA). It is a uniform coding system used to accurately describe medical, surgical, and diagnostic services provided by physicians and other healthcare professionals. The use of CPT codes is mandated by the Centers for Medicare & Medicaid Services (CMS) for reporting services under Medicare and Medicaid, and it is universally adopted by private insurers across the United States.

The Structure of a CPT Code: Categories I, II, and III

• Category I CPT Codes: These are the standard five-digit codes used to describe procedures and services that are widely performed, approved by the FDA (if applicable), and proven to be clinically effective. All primary PET scan codes are Category I codes.

• Category II CPT Codes: These are optional alphanumeric codes used for performance measurement and tracking. They are used for quality improvement initiatives and are not related to reimbursement.

• Category III CPT Codes: These are temporary alphanumeric codes for emerging technologies, services, and procedures. They allow for data collection on the utilization and efficacy of new services. If a Category III code proves its worth, it may eventually be promoted to a Category I code.

Why Accurate Coding is Non-Negotiable: Compliance, Reimbursement, and Data Integrity

1. Reimbursement: Correct codes are essential for receiving appropriate and timely payment from insurers. An incorrect code will almost certainly lead to a denial or underpayment.

2. Compliance: Incorrect coding, especially if it results in overpayment, can be construed as fraud or abuse under the False Claims Act. This can lead to audits, hefty fines, penalties, and exclusion from federal healthcare programs.

3. Data Integrity: CPT codes are used for public health reporting, epidemiological research, and tracking disease trends. Accurate coding ensures the data used to make broad healthcare decisions and policies is reliable.

4. Operational Efficiency: Clean claims with accurate codes are processed faster, reducing accounts receivable days and minimizing the administrative burden of managing denials and appeals.

4. The Core PET Imaging CPT Codes: A Deep Dive

The CPT codes for diagnostic PET imaging are organized primarily by the anatomical area scanned and whether the service includes “only” the PET imaging or is a “combination” study with concurrently acquired CT for attenuation correction and anatomical localization.

CPT 78608: Neurology – Brain PET

• Description: “Brain imaging, positron emission tomography (PET); metabolic evaluation.”

• When to Use: This code is used for a PET scan of the brain performed to evaluate metabolic activity. Common clinical applications include:

  • Pre-surgical evaluation for refractory epilepsy (to locate the epileptogenic focus).

  • Differentiating between Alzheimer’s disease and other forms of dementia (e.g., frontotemporal dementia).

  • Evaluating brain tumors (primary or metastatic) for grade, extent, and recurrence.

  • Assessing cognitive disorders and neuropsychiatric conditions.

• Key Consideration: This code is for the PET metabolic evaluation itself. The CT performed for attenuation correction is considered a integral part of the PET service and is not separately reported.

CPT 78609: Neurology – Brain PET with Physiologic or Pharmacologic Stress

• Description: “Brain imaging, positron emission tomography (PET); perfusion evaluation.”

• When to Use: This code is less common and is used when a brain PET is performed to evaluate blood flow (perfusion), often under conditions of physiologic (e.g., breath-hold, visual stimulation) or pharmacologic stress. Its use is more specialized, often in research settings for cerebrovascular disease.

5. Oncology: The Primary Domain of PET Imaging

This family of codes, introduced in a major restructuring in 2013, is the most frequently used set for PET scans. The hierarchy is based on two key differentiators:

1. With or Without CT: Does the code include “with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization” or is it “PET imaging only”?

2. Extent of Anatomy:

   • Limited Area: e.g., skull base to thighs, but a specific area like the chest is of interest.

   • Skull Base to Mid-Thigh: This is the standard field of view for most oncologic PET scans, covering the vast majority of the body where cancers occur.

   • Whole Body: This extends the imaging from the top of the skull through the feet. It is used for cancers that can metastasize to the distal extremities, such as melanoma.

The “With CT” Codes (78811, 78812, 78813)
These codes represent a PET/CT study. The CT performed is typically a low-dose, non-diagnostic CT used primarily for attenuation correction (making the PET images quantitatively accurate) and anatomical localization ( pinpointing where the FDG uptake is occurring). If a separate, dedicated diagnostic CT with contrast is performed, it may be separately reportable with specific documentation and modifiers.

• CPT 78811: …with concurrently acquired CT for attenuation correction and anatomical localization; limited area (e.g., chest for solitary nodule)

• CPT 78812: …skull base to mid-thigh. This is the workhorse code for oncology.

• CPT 78813: …whole body.

The “PET Imaging Only” Codes (78814, 78815, 78816)
These codes are for a stand-alone PET scanner without integrated CT. While these are becoming increasingly rare as PET/CT is now the standard of care, they remain in the code set for those few facilities that still operate dedicated PET units.

• CPT 78814: PET imaging only; limited area

• CPT 78815: PET imaging only; skull base to mid-thigh

• CPT 78816: PET imaging only; whole body

Crucial Note: You must choose either a “with CT” code or a “PET only” code. They are mutually exclusive. You cannot report both for the same session.

*Table 1: Summary of Primary Oncologic PET/CT CPT Codes*

6. Myocardial Perfusion PET: A Gold Standard for Cardiac Assessment

PET is increasingly recognized as a superior modality for myocardial perfusion imaging (MPI), offering higher diagnostic accuracy, lower radiation dose, and robust quantitative blood flow measurement compared to traditional SPECT imaging.

CPT 78429: Myocardial Perfusion Imaging, PET at Rest or Stress

• Description: This code describes a single PET study of the heart, performed either at rest or under stress (pharmacologic, such as with regadenoson or adenosine). It is a single point assessment of blood flow.

CPT 78430: Myocardial Perfusion Imaging, PET at Rest and Stress

• Description: This is the complete evaluation and is reported once for the entire service. It includes both the rest and the stress portions of the study, allowing for comparison of blood flow to identify areas of ischemia (reduced blood flow under stress). This is the most common code used for a full diagnostic cardiac PET MPI.

CPT 78431: Myocardial Perfusion Imaging, PET for Metabolism or Viability

• Description: This code is used to assess myocardial viability. It involves using a tracer like FDG to identify hibernating myocardium—heart muscle that is dysfunctional due to chronic lack of blood flow but is still alive and may recover function after revascularization (e.g., stenting or bypass surgery). A perfusion tracer (e.g., Rubidium-82 or Ammonia N-13) is also used, making this a multi-tracer study.

CPT 78432: Myocardial Imaging, PET for Blood Pool or Shunting (Absolute Quantification)

• Description: This is a highly specialized code used for quantitative analysis of cardiac function, such as measuring absolute myocardial blood flow (in mL/min/g of tissue) or evaluating cardiac shunts. It is used less frequently in general practice.

7. The Radiopharmaceuticals: Coding for the Tracer Itself

The CPT code covers the professional and technical components of the scan: the use of the scanner, the technologist’s time, the physicist’s support, and the radiologist’s interpretation. The cost of the radioactive tracer itself is billed separately using a HCPCS Level II code (often called a “J-code” or “A-code”).

Understanding A9586 (Fludeoxyglucose F-18 FDG)

• Code: A9586

• Description: “Injection, Fludeoxyglucose F-18 FDG, diagnostic, per study dose, up to 45 millicuries”

• Usage: This is the code for the FDG radiopharmaceutical. It is billed once per study, regardless of the dose administered (as long as it is within the 45 mCi limit, which covers nearly all adult doses). The dose is determined by patient weight and scanner timing.

Other Common HCPCS Level II Codes for PET Tracers

• A9552: Rubidium Rb-82, diagnostic, per millicurie (for cardiac perfusion)

• A9556: Sodium fluoride F-18, diagnostic, per millicurie (for bone imaging)

• A9609: Strontium chloride Sr-89, therapeutic, per millicurie (not diagnostic)

• A9590: Gallium Ga-68, dotatate, diagnostic, per study dose, up to 40 millicurie (for neuroendocrine tumors)

The J-Code Alternative: J1245
While A9586 is the standard for Medicare and many insurers, some private payers may prefer the use of J1245 (Injection, dorzolamide hydrochloride, per 500 mg) for FDG. It is critical to verify payer-specific guidelines, but A9586 is universally accepted in most contexts.

8. The Coding Workflow: From Patient Schedule to Clean Claim

Accurate coding is not an afterthought; it is an integral part of the patient journey.

1. Step 1: Order Verification and Medical Necessity: The process begins when a referring physician orders a PET scan. The scheduling staff must verify that the order is complete and that the clinical indication meets payer-specific medical necessity criteria based on NCDs and LCDs. This often involves checking the patient’s diagnosis codes (ICD-10-CM) against the payer’s policy.

2. Step 2: Patient Preparation and Scheduling: The patient is scheduled and given detailed instructions (e.g., NPO, diabetes management, avoid exercise) to ensure a high-quality scan.

3. Step 3: Performing the Scan and Documentation: The technologist performs the scan, documenting the tracer used, the dose administered, the anatomical area covered, and any patient factors relevant to the study.

4. Step 4: Image Interpretation and Report Generation: The radiologist or nuclear medicine physician interprets the images and dictates a structured report. The report is the foundation of accurate coding. It must clearly state:

   • The radiopharmaceutical and dose used.

   • That a CT was performed concurrently for attenuation correction and anatomical localization.

   • The specific anatomical extent of the scan (e.g., “from skull base to mid-thigh”).

   • The clinical indication and comparative findings.

5. Step 5: Code Assignment and Charge Capture: The coder (or automated system) reviews the finalized report and assigns the appropriate CPT code (e.g., 78812) and HCPCS code (e.g., A9586). The corresponding ICD-10-CM diagnosis code that justifies medical necessity is also assigned.

6. Step 6: Claim Submission, Denial Management, and Appeals: The claim is submitted to the payer. If denied, the team must analyze the reason, gather supporting documentation (often the full report and proof of medical necessity), and file an appeal if warranted.

9. Navigating Medical Necessity and Payer Policies

This is perhaps the most challenging aspect of PET coding. Coverage is not automatic; it is strictly governed by policies.

The Role of National Coverage Determinations (NCDs)
CMS issues NCDs that outline the specific conditions for which Medicare will cover a PET scan. For example, NCD 220.6 details coverage for FDG PET in oncology, including specific guidelines for initial staging, subsequent treatment strategy evaluation, and monitoring response to therapy for various cancer types.

Local Coverage Determinations (LCDs) and Your MAC
While NCDs set the national floor, Medicare Administrative Contractors (MACs) can issue LCDs that provide further detail or additional restrictions within their jurisdictions. It is imperative to know your MAC (e.g., Novitas Solutions, First Coast Service Options, etc.) and review their specific LCD for PET scans (often titled “Positron Emission Tomography (PET) and PET/CT”) for any unique requirements.

Common Diagnosis Codes (ICD-10-CM) Supporting Medical Necessity
The diagnosis code must align perfectly with the covered indication. Examples include:

• C34.90: Malignant neoplasm of unspecified part of unspecified bronchus or lung (for lung cancer staging)

• C18.9: Malignant neoplasm of colon, unspecified

• C85.90: Non-Hodgkin lymphoma, unspecified, unspecified site

• C61: Malignant neoplasm of prostate

• G30.9: Alzheimer’s disease, unspecified

• G40.909: Epilepsy, unspecified, not intractable, without status epilepticus

Using an unspecified code when a more specific code is available, or using a code for a non-covered indication, will guarantee a denial.

10. Future Horizons: Emerging Tracers, New Codes, and the Evolution of PET

The field of PET imaging is dynamic, with new radiotracers constantly expanding its diagnostic capabilities.

PSMA-PET for Prostate Cancer (CPT 78816)
Prostate-Specific Membrane Antigen (PSMA) PET tracers (e.g., Ga-68 PSMA-11, F-18 piflufolastat) have revolutionized the management of prostate cancer. They are exquisitely sensitive for detecting recurrent or metastatic disease at very low PSA levels. These studies are currently billed using the “PET only” code 78816 (whole body) with the respective HCPCS code for the tracer (e.g., A9591 for Ga-68 PSMA-11).

Dotatate PET for Neuroendocrine Tumors (CPT A9590)
Ga-68 Dotatate PET/CT is the gold standard for imaging well-differentiated neuroendocrine tumors (NETs), which often do not show significant FDG uptake. It is billed with CPT code 78812 (or 78813) for the imaging and HCPCS code A9590 for the dotatate tracer.

Amyloid and Tau PET for Alzheimer’s Disease and Neurologic Disorders
Tracers that bind to amyloid plaques (e.g., Florbetapir F-18) and tau tangles in the brain are powerful tools for diagnosing Alzheimer’s disease and other dementias. These are typically billed under the neurology code 78608 with their specific HCPCS codes (e.g., A9586 is not used for these).

The Growing Role of Artificial Intelligence in Quantification and Coding
AI is beginning to play a role in PET by automating tedious tasks like tumor segmentation and standardized uptake value (SUV) quantification, leading to more precise and reproducible reports. In the future, AI-powered natural language processing (NLP) may assist in reading physician reports and automatically suggesting the most accurate CPT and ICD-10 codes, reducing human error and improving efficiency.

11. Conclusion: Mastering the Code to Unlock the Value of PET

CPT codes for PET scans are the critical bridge between profound clinical utility and sustainable healthcare delivery. Accurate coding, rooted in a deep understanding of the procedure, the codeset’s structure, and complex payer policies, is a non-negotiable competency. It ensures compliance, maximizes appropriate reimbursement, and maintains the financial viability of providing this advanced diagnostic service. As PET technology continues to evolve with new tracers and applications, a commitment to ongoing education and meticulous attention to detail will remain paramount for all stakeholders in the imaging chain.

12. Frequently Asked Questions (FAQs)

Q1: Can I bill both a PET code (e.g., 78812) and a separate CT code (e.g., 71250) for a PET/CT study?
A: Generally, no. The CT performed as part of a PET/CT is typically a low-dose, non-contrast scan used solely for attenuation correction and localization. It is considered an integral part of the PET service and is bundled into the PET/CT code (78811-78813). However, if a separate, distinct, and medically necessary diagnostic CT with contrast is performed at the same session, it may be separately reportable. This requires:

• A separate written order and medical necessity for the diagnostic CT.

• A full, formal report for the diagnostic CT.

• Appending modifier -59 (Distinct Procedural Service) to the CT code to indicate it was a separate and identifiable service.
  This scenario is uncommon and subject to intense payer scrutiny.

Q2: What is the correct code for a PET/CT scan that goes from the eyes to the thighs?
A: The code 78812 is defined as “skull base to mid-thigh.” The skull base is the bottom part of the skull, not including the calvarium (the top). A scan from the “eyes” or “vertex” (top of the head) would extend beyond the skull base. If the entire brain is included, you are technically performing a “whole body” scan as defined by CPT (from the top of the head through the feet), but since the feet are not included, it creates ambiguity. In practice, most payers expect 78812 for standard oncology scans that include the brain. To avoid issues, the radiology report should describe the exact field of view. If the clinical question specifically requires brain imaging, 78608 might also be considered, but 78812 and 78608 are generally not billed together for the same session.

Q3: My patient is being scanned for lymphoma, and the physician wants images from the top of the head through the feet. Is 78813 correct?
A: Yes. For malignancies like melanoma and lymphoma that have a known propensity to metastasize to the distal extremities, a true whole-body scan (top of head through feet) is medically justified. In this case, CPT 78813 (PET/CT, whole body) is the correct code.

Q4: How do I code for a PET scan using a new tracer like Ga-68 PSMA-11?
A: As of now, you would use the “PET only” code that describes the anatomical area covered. For a whole-body PSMA-PET, you would use CPT 78816. You would then bill the tracer itself with its specific HCPCS code. For Ga-68 PSMA-11, this is A9591. It is crucial to check with individual payers for specific coverage policies and coding requirements for novel tracers, as they may have unique clinical trial requirements or prior authorization processes.

Q5: What is the single most common mistake in PET coding?
A: The most common mistake is a mismatch between the ICD-10 diagnosis code and the payer’s medical necessity policy. Using an incorrect or unsupported diagnosis code will lead to an immediate denial, even if the CPT code is perfectly correct. Always verify the patient’s specific diagnosis against the applicable NCD and LCD before the scan is performed.

13. Additional Resources

• American Medical Association (AMA): The official source for the CPT code set. Access requires a license.

  • CPT® Professional Edition

• Centers for Medicare & Medicaid Services (CMS):

  • National Coverage Determinations (NCD) Manual

  • Local Coverage Determinations (LCD) Database

• Society of Nuclear Medicine and Molecular Imaging (SNMMI): An excellent resource for clinical guidelines, coding tips, and advocacy news related to nuclear medicine.

  • SNMMI Coding & Reimbursement

• American College of Radiology (ACR): Provides resources, practice parameters, and accreditation programs for radiology, including nuclear medicine and PET.

  • ACR Practice Parameters

• Your Medicare Administrative Contractor (MAC): Find your regional MAC’s website for the most specific local policies and bulletins.